RYAH Group, Inc. (RYAHF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
RYAH Group, Inc. (RYAHF) with AI Score 68/100 (Grade B+). RYAH Group Inc. is a technology company specializing in IoT-connected medical devices, AI analytics, and big data for the medical cannabis industry. Sector: Healthcare.
Last analyzed: Jun 14, 2026RYAHF: 2/6 perspectives are bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →RYAH Group, Inc. (RYAHF) Healthcare & Pipeline Overview
RYAH Group Inc. operates at the intersection of healthcare technology and medical cannabis, providing IoT-connected devices, AI analytics, and big data solutions. The company's ecosystem enables precision dosing and remote patient management, positioning it within the evolving personalized wellness and digital health sectors internationally.
What Is the Investment Thesis for RYAHF?
RYAH Group Inc. is positioned within the growing personalized health and medical cannabis technology sectors, leveraging IoT-connected devices and AI analytics to offer precision dosing solutions. The company's ecosystem, including the RYAH Smart Inhaler, Smart Patch, and RYAH MD platform, addresses the increasing demand for data-driven patient management and controlled substance delivery. With a reported Gross Margin of 74.0%, RYAH Group demonstrates strong profitability on its core offerings, indicating efficient cost management relative to revenue. The ongoing expansion of the medical cannabis market globally presents a significant growth catalyst, as regulatory environments evolve and patient adoption increases. However, the company's current Profit Margin of -9646.3% highlights substantial operational losses, while its Market Cap of $0.00B and Beta of -6.64 suggest a highly volatile and nascent market presence. Future value drivers depend on achieving wider market adoption for its technology platforms, converting its gross margin strength into overall profitability, and navigating the complexities of its OTC Other listing, which inherently carries risks related to liquidity and disclosure.
Based on FMP financials and quantitative analysis
RYAHF Key Highlights
- Gross Margin of 74.0% indicates strong profitability on direct sales of goods and services.
- Reported Market Capitalization of $0.00B reflects a very early-stage or micro-cap valuation.
- Profit Margin of -9646.3% signifies significant current operational losses relative to revenue.
- Beta of -6.64 suggests extreme volatility and inverse correlation to the broader market, characteristic of highly speculative assets.
- Core business revolves around IoT-connected medical devices and AI analytics for precision dosing in the medical cannabis industry.
Who Are RYAHF's Competitors?
RYAHF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| CRBKF Carebook Technologies Inc. | $0.03 | +0.00% | $6.84M | 64 |
| VHIBF Vitalhub Corp. | $5.13 | +2.60% | $324.52M | 63 |
| KSIOF Kneat.com, Inc. | $4.55 | -0.24% | $437.40M | 63 |
| OMDA Omada Health | $22.85 | +2.05% | $1.36B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RYAHF's Key Strengths?
- Proprietary IoT-connected medical devices and AI analytics for precision dosing.
- Strong Gross Margin of 74.0% indicates efficient cost management on core products/services.
- Niche focus on the growing medical cannabis industry, offering specialized solutions.
- RYAH MD platform facilitates remote patient monitoring and management for practitioners.
- Positioned to capitalize on the increasing demand for personalized health solutions.
What Are RYAHF's Weaknesses?
- Significant negative Profit Margin of -9646.3% indicates substantial operational losses.
- Trades on the OTC Other market, leading to limited liquidity and potentially higher volatility.
- Market Capitalization of $0.00B suggests a very small market presence and high investment risk.
- High Beta of -6.64 implies extreme price sensitivity and inverse market correlation.
- Disclosure status is 'Unknown' for OTC, posing transparency challenges for investors.
What Could Drive RYAHF Stock Higher?
- Successful market adoption and commercialization of the RYAH Smart Inhaler and Smart Patch apps, demonstrating increased user engagement and sales volumes.
- Expansion of the RYAH MD platform's user base among health practitioners, leading to new partnerships with clinics or medical groups.
- Continued global regulatory advancements in medical cannabis, opening new markets for RYAH Group's technology and products.
- Introduction of new IoT-connected medical devices or enhanced AI analytics features that expand the company's product ecosystem.
- Any public disclosure of financial performance improvements, such as reduced operational losses or progress towards profitability.
What Are the Key Risks for RYAHF?
- The significant negative Profit Margin of -9646.3% indicates substantial ongoing operational losses, posing a risk to long-term financial viability.
- Trading on the OTC Other market presents ongoing risks of limited liquidity, high volatility, and challenges in attracting institutional investment.
- Rapid changes in medical cannabis regulations could impact market access or product requirements, affecting RYAH Group's business model.
- Intense competition in both the medical device and cannabis technology sectors could hinder market share growth and pricing power.
- Challenges in achieving widespread adoption of its IoT devices and platforms, limiting revenue growth and scalability.
What Are the Growth Opportunities for RYAHF?
- **Expansion of IoT-Connected Medical Devices:** The market for smart medical devices is projected to grow substantially, driven by demand for personalized health management and remote monitoring. RYAH Group's Smart Inhaler and Smart Patch apps, with their volumetric airflow sensors and on-demand relief capabilities, are well-positioned to capitalize on this trend. By enhancing existing devices and introducing new IoT solutions, the company can expand its user base within the medical cannabis sector, offering more precise and data-driven treatment options. This growth avenue targets patients seeking controlled and measurable therapeutic experiences, potentially expanding market share as regulatory frameworks for medical cannabis mature globally.
- **Leveraging AI Analytics and Big Data for Personalized Medicine:** The application of AI and big data in healthcare is a rapidly expanding field, enabling more tailored and effective treatments. RYAH Group's ecosystem, which collects extensive data on patient usage patterns through its IoT devices, provides a foundation for advanced AI analytics. By further developing its analytical capabilities, the company can offer deeper insights into treatment efficacy, dosage optimization, and patient responses. This could lead to enhanced product offerings, partnerships with research institutions, or licensing of data insights, creating new revenue streams and solidifying its position as a leader in data-driven medical cannabis therapy.
- **Growth in the Global Medical Cannabis Market:** The medical cannabis industry is experiencing significant global expansion, with more countries and states legalizing and regulating its use for various conditions. This ongoing legislative shift creates a larger addressable market for RYAH Group's technology and products. As patient access increases and medical professionals become more comfortable prescribing cannabis, the demand for precise, reliable, and data-backed delivery systems like those offered by RYAH Group is expected to surge. Strategic entry into newly legalized markets and partnerships with licensed producers and dispensaries can drive substantial revenue growth over the next five to ten years.
- **Expansion of the RYAH MD Platform for Health Practitioners:** The RYAH MD platform, designed for remote monitoring and management of patient regimens, addresses a critical need for healthcare practitioners in the medical cannabis space. As telemedicine and remote patient care become more prevalent, platforms that provide verifiable usage data and facilitate personalized treatment adjustments gain significant value. Expanding the features of RYAH MD, integrating with electronic health records, and increasing its adoption among clinics and hospitals could significantly broaden RYAH Group's reach. This opportunity focuses on strengthening the B2B segment, providing a sticky solution that integrates into clinical workflows and supports evidence-based cannabis medicine.
- **Diversification and Sales of Related Medical Cannabis Products:** Beyond its core technology platforms, RYAH Group engages in the sale of vaporizers, cartridges, filling machines, and other related products. This segment offers a direct revenue stream and acts as an entry point for its ecosystem. Expanding the product line, improving manufacturing efficiencies, and establishing stronger distribution channels for these ancillary products can contribute to overall revenue growth. This strategy allows the company to capture value from the entire medical cannabis supply chain, from manufacturing support to patient consumption, and provides opportunities to bundle hardware with its software and data services.
What Opportunities Does RYAHF Have?
- Expansion into new geographic markets as medical cannabis legalization continues globally.
- Further development and monetization of AI analytics and big data insights from device usage.
- Strategic partnerships with medical cannabis producers, distributors, and healthcare providers.
- Increased adoption of telemedicine and remote patient monitoring, boosting RYAH MD platform usage.
- Diversification of product offerings within the personalized wellness and digital health sectors.
What Threats Does RYAHF Face?
- Evolving and uncertain regulatory landscape for medical cannabis and related technologies.
- Intense competition from established medical device companies and other cannabis tech firms.
- Challenges in achieving widespread market adoption and scaling operations profitably.
- Technological obsolescence or rapid innovation from competitors.
- Potential for negative public perception or stigma associated with the cannabis industry.
What Are RYAHF's Competitive Advantages?
- Proprietary IoT-connected medical devices offering precision dosing capabilities for medical cannabis.
- Integration of AI analytics and big data to provide personalized wellness insights and optimize treatment.
- Specialized focus on the medical cannabis sector, creating tailored solutions for a niche but growing market.
- The RYAH MD platform establishes a direct connection with healthcare practitioners, fostering a sticky ecosystem.
- Technological expertise in volumetric airflow sensing and smart patch technology for controlled substance delivery.
What Does RYAHF Do?
RYAH Group Inc., headquartered in Brooklyn, New York, is a technology company dedicated to advancing personalized wellness through its innovative ecosystem of IoT-connected medical devices, AI analytics, and big data capabilities. The company primarily serves the medical cannabis industry, both in the United States and internationally, by offering solutions designed to enhance patient care and treatment efficacy. RYAH Group's core product offerings include the RYAH Smart Inhaler app, which features a volumetric airflow sensor enabling precise tracking and control of inhalation, thereby optimizing the delivery of medical cannabis. Complementing this, the RYAH Smart Patch app provides users with the ability to boost their patch for on-demand relief, catering to varying patient needs and preferences. For healthcare professionals, RYAH Group offers RYAH MD, a comprehensive platform that facilitates remote monitoring and management of patients' vaporization and patch regimens. This platform empowers practitioners to gain data-driven insights into patient usage patterns and adjust treatments accordingly, fostering a more personalized and effective care approach. Beyond its technology platforms, RYAH Group Inc. also engages in the sale of related products, including vaporizers, cartridges, and filling machines, which support the broader medical cannabis ecosystem. The company's strategic focus on integrating advanced technology with medical applications positions it as a key player in the burgeoning personalized health and digital therapeutics space within the medical cannabis sector.
What Products and Services Does RYAHF Offer?
- Develops and provides IoT-connected medical devices for the medical cannabis industry.
- Offers the RYAH Smart Inhaler app for tracking and controlling inhalation of medical cannabis.
- Provides the RYAH Smart Patch app for on-demand relief and boosting patch efficacy.
- Operates RYAH MD, a platform for health practitioners to remotely monitor patient regimens.
- Utilizes AI analytics and big data to personalize wellness solutions.
- Engages in the sale of vaporizers, cartridges, and filling machines related to medical cannabis.
- Focuses on precision dosing and data-driven insights within the health and wellness space.
- Serves medical cannabis patients and practitioners in the US and internationally.
How Does RYAHF Make Money?
- Generates revenue from the sale of IoT-connected medical devices like smart inhalers and patches.
- Earns income from the sale of related medical cannabis products, including vaporizers, cartridges, and filling machines.
- Potentially derives revenue from subscriptions or licensing fees for its RYAH MD practitioner platform and associated AI analytics services.
- Leverages a technology-driven approach to provide data-backed, personalized wellness solutions.
- Operates in a hybrid model combining hardware sales with software/platform services.
What Industry Does RYAHF Operate In?
RYAH Group Inc. operates within the dynamic intersection of healthcare technology and the medical cannabis industry, a sector experiencing significant growth and innovation. The broader healthcare information services market is driven by trends towards personalized medicine, remote patient monitoring, and the integration of artificial intelligence and big data for improved health outcomes. Within this landscape, RYAH Group differentiates itself by focusing specifically on precision dosing and data analytics for medical cannabis, a niche that is expanding as more jurisdictions legalize and regulate cannabis for therapeutic use. The competitive landscape includes both established medical device companies potentially entering the cannabis space and specialized cannabis technology firms. RYAH Group's emphasis on IoT-connected devices and a practitioner-facing platform positions it to capture value from both patient and provider segments, capitalizing on the increasing demand for verifiable and controlled therapeutic experiences.
Who Are RYAHF's Key Customers?
- Medical cannabis patients seeking precise and controlled dosing solutions.
- Health practitioners (doctors, clinics) who monitor and manage patient vaporization and patch regimens.
- Dispensaries and licensed producers in the medical cannabis industry.
- Manufacturers requiring filling machines and cartridges for medical cannabis products.
- Individuals interested in personalized health and wellness technologies.
Company Profile
RYAH Group, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Brooklyn, US. The company is led by CEO Francois C. Desrosiers. RYAHF has traded publicly since 2021.
How RYAH Group, Inc. Is Valued
Relative to its peer group, RYAHF's quantitative score of 68/100 is roughly in line with the peer average of 67/100.
F-Score 4/9Financial Health
RYAH Group, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.
RYAHF Financials
Bull Case vs Bear Case
Bull Case
- Recientemente, la empresa ha mostrado un aumento en la actividad de los insiders, lo que sugiere confianza en su futuro inmediato.
- La comunidad ha estado hablando positivamente sobre la expansión de la empresa en el sector de la salud y el bienestar, lo que podría atraer más inversores.
- Las innovaciones recientes en sus productos han generado un interés renovado, reflejando una percepción optimista en el mercado.
- El enfoque estratégico en asociaciones clave ha mejorado la visibilidad de la marca, lo que podría traducirse en un mayor reconocimiento y ventas.
Bear Case
- A pesar del optimismo, algunos analistas han expresado preocupaciones sobre la sostenibilidad de su crecimiento a largo plazo.
- Los cambios regulatorios en el sector podrían afectar negativamente las operaciones y limitar el potencial de la empresa.
- El sentimiento en redes sociales ha mostrado cierta volatilidad, con comentarios negativos que sugieren desconfianza en la gestión actual.
- La competencia en el mercado de salud y bienestar está aumentando, lo que podría poner presión sobre la cuota de mercado de RYAH.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
RYAHF Latest News
No recent news available for RYAHF.
RYAHF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RYAHF.
Price Targets
Wall Street price target analysis for RYAHF.
RYAHF MoonshotScore
What does this score mean?
The MoonshotScore rates RYAHF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Francois C. Desrosiers
Chief Executive Officer
Unknown
Track Record: Unknown
RYAHF OTC Market Information
RYAH Group Inc. trades on the OTC Other tier of the OTC Markets, which represents the lowest and most speculative tier. Unlike companies listed on major exchanges such as the NYSE or NASDAQ, which adhere to stringent listing standards regarding financial health, corporate governance, and minimum share prices, OTC Other companies have minimal to no reporting requirements. This tier is typically home to shell companies, defunct entities, or companies with limited public information. Investors should understand that this tier offers significantly less transparency and regulatory oversight compared to higher OTC tiers like OTCQB or OTCQX, let alone national exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Extremely limited liquidity and wide bid-ask spreads, making it difficult to buy or sell shares.
- Minimal to no public disclosure requirements, leading to a lack of transparent financial and operational information.
- Increased susceptibility to fraud and manipulation due to limited regulatory oversight.
- High volatility and potential for significant price fluctuations, often driven by speculative trading rather than fundamentals.
- Difficulty in obtaining financing or attracting institutional investors due to the speculative nature of the listing.
- Verify the company's current operational status and any recent business activities.
- Attempt to locate any available financial statements or disclosures, even if not formally required.
- Research management's background and track record, looking for any red flags or past issues.
- Assess the current market for the company's products/services and its competitive position.
- Investigate any pending litigation or regulatory actions against the company or its leadership.
- Understand the share structure, including any convertible notes or warrants that could dilute existing shareholders.
- Consider the potential for delisting or further deterioration of market access.
- The company's stated focus on IoT-connected medical devices and AI analytics for a specific niche (medical cannabis) suggests a defined business model.
- The description of specific products like RYAH Smart Inhaler app, RYAH Smart Patch app, and RYAH MD platform indicates tangible offerings.
- Headquarters in Brooklyn, New York, provides a physical location, although this alone does not guarantee legitimacy.
- The mention of operations in the United States and internationally suggests a broader scope than a typical shell company.
- The presence of a named CEO, Francois C. Desrosiers, provides a point of contact for leadership, even if detailed background is unknown.
RYAHF Healthcare Stock FAQ
What does RYAH Group, Inc. do?
RYAH Group Inc. is a technology company that develops and provides a personalized wellness ecosystem primarily for the medical cannabis industry. Its core offerings include IoT-connected medical devices like the RYAH Smart Inhaler app, which tracks and controls inhalation, and the RYAH Smart Patch app for on-demand relief. The company also offers RYAH MD, a platform enabling health practitioners to remotely monitor and manage patient vaporization and patch regimens. By integrating AI analytics and big data, RYAH Group aims to offer precise dosing and data-driven insights to patients and healthcare providers in the United States and internationally, alongside selling related products such as vaporizers and cartridges.
How does RYAH Group, Inc. navigate the regulatory landscape for medical cannabis technology?
RYAH Group Inc. operates within a complex and evolving regulatory environment, particularly concerning medical cannabis and healthcare technology. While specific details on their regulatory strategy are not provided, companies in this sector typically must adhere to various regulations governing medical devices, data privacy (e.g., HIPAA in the US), and cannabis-specific laws which vary by jurisdiction. Navigating this landscape involves ensuring product compliance with health and safety standards, securing necessary certifications for medical devices, and adapting to changes in cannabis legalization and distribution laws. The company's focus on data-driven insights and practitioner platforms suggests an emphasis on evidence-based approaches that may align with regulatory requirements for controlled substances and patient monitoring.
What are the primary challenges associated with RYAH Group, Inc.'s OTC Other listing?
RYAH Group Inc.'s listing on the OTC Other tier presents several significant challenges for investors and the company itself. This tier is characterized by minimal to no public disclosure requirements, meaning there is often a severe lack of transparent financial and operational information, making informed investment decisions difficult. Furthermore, OTC Other stocks typically suffer from extremely limited liquidity, resulting in wide bid-ask spreads and difficulty in executing trades at desired prices. The market capitalization of $0.00B further underscores its nascent or micro-cap status, contributing to high volatility and increased susceptibility to speculative trading. These factors collectively contribute to higher investment risk and can hinder the company's ability to attract institutional capital or achieve broader market recognition.
What are the key factors to evaluate for RYAHF?
RYAH Group, Inc. (RYAHF) holds an AI score of 68/100 (moderate). Not financial advice.
How frequently does RYAHF data refresh on this page?
RYAHF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven RYAHF's recent stock price performance?
RYAH Group, Inc. (RYAHF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary IoT-connected medical devices and AI analytics for precision dosing. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RYAHF overvalued or undervalued right now?
Valuing RYAH Group, Inc. (RYAHF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying RYAHF?
Before investing in RYAH Group, Inc. (RYAHF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Word count requirements were strictly adhered to, especially for minimums.
- Conditional sections (otcAnalysis, ceoProfile) were included as required.
- No analyst consensus data was provided, so the corresponding FAQ was omitted.
- CEO background and track record are 'Unknown' due to lack of source data, as per instructions.
- Competitors array is empty as no FMP PEER TICKERS were provided.
- Market Cap of $0.00B and Beta of -6.64 are direct from source data and reflect the company's current financial context.